Edition:
United States

People: OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

1.36USD
16 Nov 2018
Change (% chg)

$-0.04 (-2.86%)
Prev Close
$1.40
Open
$1.39
Day's High
$1.40
Day's Low
$1.32
Volume
10,852
Avg. Vol
23,478
52-wk High
$5.55
52-wk Low
$1.32

Gould, Elisha 

Elisha P. Gould is Independent Director of OncoMed Pharmaceuticals, Inc. Mr. Gould has been employed at Adams Street Partners, LLC, a private equity firm or its predecessor organizations since 1994, and he is currently a Partner and Head of Direct Investments. Mr. Gould currently serves on the boards of directors of several privately held healthcare technology companies. Mr. Gould received an A.B. from Dartmouth College and an M.B.A. from the Stanford University Graduate School of Business.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --